SynthesisSleep & breathing = Schlaf & Atmung2025
Prevalence and characteristics of pulmonary hypertension in obstructive sleep apnea: a systematic review and meta-analysis.
Synthesis in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPulmonary hypertension (PH) is a serious cardiovascular complication that can be associated with obstructive sleep apnea (OSA). We aimed to assess the prevalence and characteristics of PH in OSA patients.
methodOn May 13, 2025, a comprehensive literature search was performed to identify studies reporting the prevalence of PH in patients with OSA, or studies that compared OSA patients with and without PH. Data were pooled and subgroup-analyses, sensitivity-analyses and meta-regressions were performed based on apnea-hypopnea-index (AHI) thresholds, PH diagnostic methods, and study characteristics.
resultsOf 4,852 records, 53 included in the systematic-review and 46 in the quantitative-analysis. Across them, 1,190 OSA patients had PH (55.5%male) and 2,967 did not (64.5%male). The pooled prevalence of PH among OSA patients using AHI ≥ 5 criteria was 29.3% (95%CI[19.4-41.8], I²=94%). Sensitivity-analyses showed similar prevalence estimates when limited to studies using right-heart-catheterization (RHC)(29.6%) or those excluding small sample-sizes (< 50participants:30.9%) or retrospective designs (30.3%). Prevalence increased to 35.5% in studies using AHI ≥ 10 as the diagnostic-threshold. However, no significant difference in PH prevalence was found between mild-to-moderate and severe OSA (OR = 0.976[0.658-1.448], I²=47%). OSA patients with PH had significantly higher body-mass-index (BMI) (mean-difference (MD) = 3.432,P < 0.001), AHI (MD = 12.6,P < 0.001), ODI (standard-mean-difference (SMD) = 0.497), and T < 90% (SMD = 0.641), and lower meanSpO₂ (SMD = - 0.885) compared to those without PH. Age and sex were not different.
conclusionsPH is relatively common among patients with OSA, with a pooled prevalence of approximately 29-31%. While OSA severity markers such as AHI and ODI were higher in PH patients, no consistent severity-dependent association with PH prevalence was observed.
Indexed as
Identifiers
41296161What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.